跳至主要内容
临床试验/NCT02150655
NCT02150655已完成早期 1 期

Pilot Study Investigating Bacteria (Microbiota), Their By-products (Metabolome) and Environmental Toxins in Relation to Reproductive Health in Rwandan Women.

Western University, Canada1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2012年9月1日最近更新:
适应症
干预措施

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
maintenance of healthy vaginal microbiota

研究概览

简要总结

The overall objective of this clinical pilot study is to determine at a random sampling time, the vaginal microbiome and metabolome of pregnant women, and to see if infection (bacterial vaginosis, vulvovaginal candidiasis, malaria) and exposure to environmental toxins affects could alter pregnancy and conception outcomes. It is hypothesized that infection and toxins will alter the vaginal microbiome and metabolome, increasing the risk of preterm labour and infertility in Rwandan women. In a sub-group of subjects, a preliminary assessment of the ability of orally administered probiotic lactobacilli to restore the vaginal microbiota to a healthy state and lower environmental toxins will be completed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women between the ages of 18 and 55.

排除标准

  • *Current infection of gonorrhoea, *Chlamydia, genital warts, *active genital herpes lesions, *active syphilis; *urinary tract infection including pyelonephritis (an ascending urinary tract infection); *receiving drug therapy that may affect the vaginal flora; *had unprotected sexual intercourse (vaginal or oral) within the past 48 hours; *have used a vaginal douche, genital deodorant, or genital wipe products in the past 48 hours; *have taken any 'acidophilus' 'bifidobacteria' or probiotic health food supplements in the past 48 hours; *are menstruating at time of clinical visit.

研究组 & 干预措施

Probiotic

Experimental

Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 oral capsules

干预措施: Lactobacillus GR-1 and Lactobacillus RC-14 oral capsules (Biological)

Placebo

Placebo Comparator

Sugar pill

干预措施: Placebo (Biological)

结局指标

主要结局

maintenance of healthy vaginal microbiota

时间窗: 1 month

The change in relative abundance of healthy lactobacilli and species associated with bacterial vaginosis after one month probiotic intervention will be assessed using 16S rRNA gene sequencing.

次要结局

  • Reduction of environmental toxins in blood by lactobacilli(1 month)

研究者

发起方
Western University, Canada
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Gregor Reid

Director, Canadian R&D Centre for Probiotics

Western University, Canada

研究点 (1)

Loading locations...

相似试验